プレスリリース・ニュースリリース配信サービスのPR TIMES
  • Top
  • テクノロジー
  • モバイル
  • アプリ
  • エンタメ
  • ビューティー
  • ファッション
  • ライフスタイル
  • ビジネス
  • グルメ
  • スポーツ

PR TIMESのご利用について

資料をダウンロード

SDKI Inc.
会社概要

甲状腺機能検査市場ータイプ別(TSHテスト、T4テスト、T3テスト)、エンドユーザー別(病院、診断研究所、研究所)、および地域別ー世界的な予測2030年

SDKI Inc.

SDKI Inc.は、甲状腺機能検査市場の新レポートを2021年07月12日に発刊しました。この調査には、甲状腺機能検査市場の成長に必要な統計的および分析的アプローチが含まれています。レポートで提供される主要な産業の洞察は、市場の既存のシナリオに関する読者に市場の概要についてのより良いアイデアを提供します。さらに、レポートには、市場の成長に関連する現在および将来の市場動向に関する詳細な議論が含まれています。

レポートのサンプルURL
https://www.sdki.jp/sample-request-109432

The thyroid function testing market is estimated to grow from a market value of US $ 1.68 billion in 2022 to US $ 2.51 billion by 2030, with a CAGR of 5.9% during the forecast period. Market growth may be primarily due to factors such as an increased incidence of thyroid disorders, increased awareness of thyroid disorders, and an increased prevalence of lifestyle-related diseases. Increasing elderly population and increased consumption of alcohol and tobacco are also contributing to market growth. In addition, factors such as increased awareness of early screening of diseases and the existence of advanced diagnostic laboratories are also driving the growth of the thyroid function testing market. However, US adverse health care reforms could curb the growth of this market.

Market Segments The

thyroid function testing market is divided by type (TSH test, T4 test, T3 test), end user (hospital, diagnostic laboratory, laboratory), and region. These segments are further subsegmented based on a variety of factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

The hospital segment is projected to grow at a maximum CAGR during the forecast period.

Based on end users, the market is categorized into hospitals, diagnostic laboratories, laboratories, and other end users. The hospital segment is expected to grow at a maximum CAGR during the forecast period. Massive thyroid function tests performed in hospital-based laboratories around the world, increased patient numbers (and subsequent increases in the number of clinical tests performed in hospitals), and hospital-sponsored public medical awareness The increase in the number of campaigns is a driver of growth in this segment.

Regional overview

The Asia Pacific market is expected to grow at a maximum CAGR during the 2022-2030 forecast period. The high growth rate of this segment is due to the large elderly population, universal health insurance reimbursement policies, and the well-developed health care system in Japan. The high burden of thyroid disease, the increasing disposable income of China's middle-class population, and the presence of a large patient population are also several factors driving market growth. In addition, increased access to medical facilities and improved medical infrastructure in India are other major drivers of market growth in the region.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, Other Latin) USA); Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy, Spain) , Hungary, Belgium, Netherlands, Luxembourg, NORDIC, Poland, Turkey, Russia and other Europe).

Major key players on the market

Key players in the thyroid function testing market include Thermo Fisher (USA), Abbott (USA), Roche (Switzerland), DiaSorin (Italy), Danaher (USA), Kronus (USA), Merck (Germany), Cortez Diagnostics. These include (US), bioMérieux (France), Qualigen (US), and Autobio Diagnostics (China). The study includes a detailed competitive analysis of these leading companies in the thyroid function testing market, company profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/reports/thyroid-function-test-market/109432

SDKIInc. Company Profile
SDKI Inc.'s goals are Japan, China, the United States, Canada, the United Kingdom, Germany, etc. , Is to reveal the market scenarios of different countries. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With a trusted and customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

このプレスリリースには、メディア関係者向けの情報があります

メディアユーザーログイン既に登録済みの方はこちら
メディアユーザー新規登録無料

メディアユーザー登録を行うと、企業担当者の連絡先や、イベント・記者会見の情報など様々な特記情報を閲覧できます。※内容はプレスリリースにより異なります。

すべての画像


種類
調査レポート
ダウンロード
プレスリリース素材

このプレスリリース内で使われている画像ファイルがダウンロードできます

会社概要

SDKI Inc.

21フォロワー

RSS
URL
https://www.sdki.jp
業種
サービス業
本社所在地
600 S Tyler St, Suite 2100 #140 Amarillo, TX, 79101 日本オフィス : 150-8512 東京都渋谷区桜丘町26-1 セルリアンタワー5階
電話番号
50-5050-9337
代表者名
Furukawa Isao
上場
未上場
資本金
-
設立
2016年12月
トレンド情報をイチ早くお届けPR TIMESを友達に追加PR TIMESのご利用について資料をダウンロード